Arcus Biosciences
RCUS
RCUS
185 hedge funds and large institutions have $814M invested in Arcus Biosciences in 2024 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 68 increasing their positions, 70 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
3% less repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 70
4% less funds holding
Funds holding: 193 → 185 (-8)
25% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 28
Holders
185
Holding in Top 10
2
Calls
$3.79M
Puts
$2.2M
Top Buyers
| 1 | +$9.33M | |
| 2 | +$9.22M | |
| 3 | +$9.16M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$6.74M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.38M |
Top Sellers
| 1 | -$11.7M | |
| 2 | -$6.36M | |
| 3 | -$4.49M | |
| 4 |
TI
Trexquant Investment
Stamford,
Connecticut
|
-$2.52M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.37M |